Antibody-drug conjugates — Manufacturing precision medicines

Monoclonal antibody intermediates require precise engineering and controlled handling to ensure compatibility with linker-payload complexes and maintain integrity through conjugation, purification, and formulation. Each stage presents challenges in preserving product quality, operator safety, and process efficiency.

Understand how advanced mixing, filtration, and purification technologies reduce impurities, enhance yields, and streamline bioprocessing.